Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives

References

• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000;10:575–601
   Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms. Chem Rev 2012;112:4421–68
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81
   PubMed Web of Science ®Google Scholar
• Alterio V, De Simone G, Monti SM, et al. Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides – solution and crystallographic studies. Bioorg Med Chem Lett 2007;17:4201–7
   PubMed Web of Science ®Google Scholar
• Kaur IP, Smitha R, Aggarwal D, Kapil M. Acetazolamide: future perspective in topical glaucoma therapeutics. Int J Pharm 2002;248:1–14
   PubMed Web of Science ®Google Scholar
• Celebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007;116:322–7
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases-an overview. Curr Pharm Des 2008;14:603–14
   PubMed Web of Science ®Google Scholar
• Supuran CT. Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulphonamides. Curr Pharm Des 2008;14:641–8
   PubMed Web of Science ®Google Scholar
• Sjoüblom B, Polentarutti M, Djinovic-Carugo K. Structural study of X-ray induced activation of carbonic anhydrase. Proc Natl Acad Sci USA 2009;106:10609–13
   Google Scholar
• Şentürk M, Gülçin İ, Daştan A, et al. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. Bioorg Med Chem 2009;17:3207–11
   PubMed Web of Science ®Google Scholar
• Clare BW, Supuran CT. A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors. Expert Opin Drug Metab Toxicol 2006;2:113–37
   PubMed Web of Science ®Google Scholar
• Çoban TA, Beydemir Ş, Gülçin İ, Ekinci D. Morphine inhibits erythrocyte carbonic anhydrase in vitro and in vivo. Biol Pharm Bull 2007;30:2257–61
   PubMed Web of Science ®Google Scholar
• Innocenti A, Hilvo M, Scozzafava A, et al. Carbonic anhydrase inhibitors: inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett 2008;18:3593–6
   PubMed Web of Science ®Google Scholar
• Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 1997;74:1–20
   PubMed Web of Science ®Google Scholar
• Öztürk Sarıkaya SB, Topal F, Şentürk M, et al. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. Bioorg Med Chem Lett 2011;21:4259–62
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Conway J. Carbonic anhydrase: its inhibitors and activators. Boca Raton (FL): CRC Press; 2004:243–54
   Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets-an overview. Curr Top Med Chem 2007;7:825–33
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–50
   PubMed Web of Science ®Google Scholar
• Innocenti A, Gülçin İ, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Antioxidant polyphenol natural products effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett 2010;20:5050–3
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. X-ray crystallography of CA inhibitors and its importance in drug design. In: Supuran CT, Winum JY, eds. In drug design of zinc-enzyme inhibitors: functional, structural, and disease applications. Hoboken (NJ): Wiley; 2009:73–138
   Google Scholar
• Duda DM, Tu C, Fisher SZ, et al. Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer. Biochemistry 2005;44:10046–53
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Monti M, Hilvo MS, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2008;74:164–75
   Web of Science ®Google Scholar
• Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233–8
   PubMed Web of Science ®Google Scholar
• Harig M, Neumann B, Stammler HG, Kuck D. 2,3,6,7,10,11-Hexamethoxytribenzo-triquinacene: synthesis, solid-state structure and functionalization of a rigid analogue of cyclotriveratrylene. Eur J Org Chem 2004;11:2381–97
   Web of Science ®Google Scholar
• Mitter PC. Some derivatives of 4-phenylchroman. J Ind Chem Soc 1931;8:271–6
   Google Scholar
• Garofano T, Oliverio A. The influence of o-substituents on the reactivity of aryl ketones. I. Influence of o-substituents on the reactivity of benzophenone. Annal di Chim 1957;47:260–84
   Google Scholar
• Gazave JM, Rancurel A, Grenier G. Pharmaceutical composition containing at least one diphenyl-substituted compound. Ger Offen Patent 1975, DE 2501443. Chem Abstr 1975;83:188522
   Google Scholar
• Konig B, Kostanecki Sv. Leuco-compounds of hydroxyketones. Ber Deutsch Chem Gesellschaft 1907;39:4027–31
   Google Scholar
• Fukazawa N, Odate M, Suzuki T, et al. Preparation of heterocyclic compounds as anticancer drug potentiators. Eur Patent Appl 1990, Chem Abstr 1990;113:152275
   Google Scholar
• Valette. Mono- and polyalkyl- or halogen-substituted derivatives of benzohydrylamine and symmetrical diphenylethylamine. Bull Soc Chim Fr 1930;47:289–300
   Google Scholar
• Öztürk Sarıkaya SB, Gülçin İ, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids. Chem Biol Drug Design 2010;75:515–20
   PubMed Web of Science ®Google Scholar
• Şentürk M, Gülçin İ, Beydemir Ş, et al. In vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds. Chem Biol Drug Design 2011;77:494–9
   PubMed Web of Science ®Google Scholar
• Gülçin İ, Beydemir Ş, Büyükokuroğlu ME. In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biol Pharm Bull 2004;27:613–16
   PubMed Web of Science ®Google Scholar
• Beydemir Ş, Gülçin İ. Effect of melatonin on carbonic anhydrase from human erythrocyte in vitro and from rat erythrocyte in vivo. J Enzyme Inhib Med Chem 2004;19:193–7
   PubMed Web of Science ®Google Scholar
• Wilbur KM, Anderson NG. Electrometric and colorimetric determination of carbonic anhydrase. J Biol Chem 1976;176:147–54
   Google Scholar
• Aras Hisar Ş, Hisar O, Beydemir Ş, et al. Effect of vitamin E on carbonic anhydrase enzyme activity in rainbow trout (Oncorhynchus mykiss) erythrocytes in vitro and in vivo. Acta Vet Hung 2004;52:413–22
   PubMed Web of Science ®Google Scholar
• Verpoorte JA, Metha S, Edsall JT. Esterase activities of human carbonic anhydrase B and C. J Biol Chem 1967;242:4221–9
   PubMed Web of Science ®Google Scholar
• Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;57:685–93
   Google Scholar
• Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54
   PubMed Web of Science ®Google Scholar
• Gülçin İ, Küfrevioğlu Öİ, Oktay M. Purification and characterization of polyphenol oxidase from nettle (Urtica dioica L.) and inhibition effects of some chemicals on the enzyme activity. J Enzyme Inhib Med Chem 2005;20:297–302
   PubMed Web of Science ®Google Scholar
• Laemmli DK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5
   PubMed Web of Science ®Google Scholar
• Çetinkaya Y, Menzek A, Sahin E, Balaydın HT. Selective O-demethylation during bromination of (3,4-dimethoxyphenyl)(2,3,4-trimethoxyphenyl)methanone. Tetrahedron 2011;67:3483–9
   Google Scholar
• Çetinkaya Y, Göçer H, Menzek A, Gülçin İ. Synthesis and antioxidant properties of (3,4-dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives. Arch Pharm Chem Life Sci 2011;345:323–34
   Google Scholar
• Nar M, Çetinkaya Y, Gülçin İ, Menzek A. (3,4-Dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and its derivatives as carbonic anhydrase isoenzymes inhibitors. J Enzyme Inhib Med Chem 2012. [Epub ahead of print]. doi: 10.3109/14756366.2012.670807
   Google Scholar
• Balaydın HT, Akbaba Y, Menzek A, et al. First and short syntheses of biologically active, naturally occurring brominated mono- and dibenzyl phenols. Arkivoc 2009;14:75–87
   Google Scholar
• Hosangadi BD, Kasbekar AB, Nabar MJ, Desai RC. Novel reactions with polyphosphoric acid II. Decarboxylative acetylation, trans-carbonylation, and other reactions of substituted aromatic carboxylic acids. Ind J Chem 1973;11:711–13
   Google Scholar
• Lantano B, Aguirre JM, Ugliarolo EA, et al. Scope of the formal [3 + 2] cycloaddition for the synthesis of five-membered ring of functionalized indanes. Tetrahedron 2012;68:913–21
   Google Scholar
• Göksu S, Seçen H, Sütbeyaz Y. One-pot and stereospecific synthesis of cis-1,2-diazides via Mitsunobu reaction of epoxides. Synthesis-Stuttgart 2002;16:2373–8
   Google Scholar
• Göksu S, Seçen H. Concise syntheses of 2-aminoindans via indan-2-ol. Tetrahedron 2005;61:6801–7
   Web of Science ®Google Scholar
• Pastorekova S, Vullo D, Nishimori I, et al. Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. Bioorg Med Chem 2008;16:3530–6
   PubMed Web of Science ®Google Scholar